| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |